Adverum Biotechnologies I...

NASDAQ: ADVM · Real-Time Price · USD
2.82
0.05 (1.81%)
At close: Aug 15, 2025, 3:59 PM
2.81
-0.35%
After-hours: Aug 15, 2025, 06:04 PM EDT

Adverum Biotechnologies Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1M 3.6M n/a 7.5M
Cost of Revenue
3.65M 5.64M 6.53M 4.64M
Gross Profit
-2.65M -2.04M -6.53M 2.85M
Operating Income
-153.16M -128.94M -155.01M -145.06M
Interest Income
n/a n/a n/a n/a
Pretax Income
-130.93M -123.19M -154.46M -145.54M
Net Income
-130.93M -122.12M -154.54M -145.54M
Selling & General & Admin
63.12M 49.91M 57.86M 64.44M
Research & Development
77.04M 77.48M 99.28M 89.18M
Other Expenses
n/a 5.15M -8.65M -5.71M
Operating Expenses
140.16M 132.54M 148.48M 147.91M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
154.16M 132.54M 155.01M 152.56M
Income Tax Expense
n/a -1.08M 74K n/a
Shares Outstanding (Basic)
19.78M 57.98M 57.98M 98.36M
Shares Outstanding (Diluted)
19.78M 57.98M 57.98M 98.36M
EPS (Basic)
-6.62 -2.02 -2.67 -1.48
EPS (Diluted)
-6.62 -2.02 -2.67 -1.48
EBITDA
-127.27M -117.55M -147.93M -140.9M
EBIT
-130.93M -123.19M -154.46M -146.12M
Depreciation & Amortization
3.65M 5.64M 6.53M 4.64M